Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-01
DOI
10.1002/ijc.34781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts
- (2023) Takahiko Ito et al. Scientific Reports
- Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status
- (2021) Xiaoqin Zhu et al. MODERN PATHOLOGY
- Recruitment of KMT2C/MLL3 to DNA damage sites mediates DNA damage responses and regulates PARP inhibitor sensitivity in cancer
- (2021) Antao Chang et al. CANCER RESEARCH
- Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes
- (2021) Jordan Aldersley et al. MOLECULAR CANCER RESEARCH
- Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- (2021) S. Rao et al. ANNALS OF ONCOLOGY
- KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer
- (2021) Xinhua Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma
- (2021) Soledad Iseas et al. Translational Oncology
- Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
- (2021) A. Moreira et al. ESMO Open
- A pilot study of tazemetostat and MK-3475 (pembrolizumab) in advanced urothelial carcinoma (ETCTN 10183).
- (2020) Joshua J. Meeks et al. JOURNAL OF CLINICAL ONCOLOGY
- The landscape of viral associations in human cancers
- (2020) Marc Zapatka et al. NATURE GENETICS
- Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis
- (2020) Helen Kelly et al. Lancet HIV
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study
- (2020) Diane Bruyere et al. MODERN PATHOLOGY
- Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
- (2020) Dapeng Hao et al. GUT
- The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
- (2019) Theodoros Rampias et al. EMBO REPORTS
- A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy
- (2019) I. Parwaiz et al. CLINICAL ONCOLOGY
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival
- (2018) C. Dubot et al. EUROPEAN JOURNAL OF CANCER
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
- (2017) Van Morris et al. MOLECULAR CANCER RESEARCH
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
- (2017) Wulfran Cacheux et al. Oncotarget
- The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers
- (2017) Luc G. T. Morris et al. JAMA Oncology
- Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
- (2016) J. H. Chung et al. ANNALS OF ONCOLOGY
- Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
- (2016) Wulfran Cacheux et al. BRITISH JOURNAL OF CANCER
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
- (2015) Brandon G. Smaglo et al. Oncotarget
- Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma
- (2014) C. R. Pickering et al. CLINICAL CANCER RESEARCH
- KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
- (2014) Andrea Casadei Gardini et al. PLoS One
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
- (2013) Beifang Niu et al. BIOINFORMATICS
- Changing Patterns of Anal Canal Carcinoma in the United States
- (2013) Rebecca A. Nelson et al. JOURNAL OF CLINICAL ONCOLOGY
- The MLL3/MLL4 Branches of the COMPASS Family Function as Major Histone H3K4 Monomethylases at Enhancers
- (2013) D. Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors
- (2013) Matthias Lechner et al. Genome Medicine
- Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials
- (2012) Carine A. Bellera et al. EUROPEAN JOURNAL OF CANCER
- Signature patterns of human papillomavirus type 16 in invasive anal carcinoma
- (2012) Séverine Valmary-Degano et al. HUMAN PATHOLOGY
- Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways
- (2010) Serge J. Smeets et al. INTERNATIONAL JOURNAL OF CANCER
- HPV E6 protein interacts physically and functionally with the cellular telomerase complex
- (2009) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4
- (2009) J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search